
The Institute for Policy Innovation (IPI) released new polling, demonstrating that while 50% of Texans see inflation as the biggest issue facing America today, they overwhelmingly believe current efforts to regulate the tech industry will lead to higher consumer prices. Not only do Texans believe more regulation will raise prices, they also feel that Congress does not understand how tech companies work well enough to regulate them (64%).
“Texans don’t see tech regulation as important or as a priority for Congress,” said Tom Giovanetti, President of the Institute for Policy Innovation. “Voters across the political spectrum want Congress to concentrate on addressing pocketbook issues like the rising cost of living before regulating an industry that they find generally makes their lives easier.”
In addition to the role tech regulation plays in rising costs, poll results show that Texans believe more government regulation will lead to discrimination of certain viewpoints online. Texans consider user private data protection and protecting children from predators online as the most important issues facing the tech industry and government regulators.
The poll was conducted in Texas with registered voters between August 30 – September 4, 2022 and was a mix of web panels and text-to-web polling with a margin of error of +/- 3.9 percentage points.
The Institute for Policy Innovation (IPI) is a free-market policy think tank that focuses on issues related to economic growth, innovation, limited government and individual liberty.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas